- Home
- SSP vs BWAY Comparison
SSP vs BWAY Comparison
Compare SSP & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSP
- BWAY
- Stock Information
- Founded
- SSP 1878
- BWAY 2003
- Country
- SSP United States
- BWAY Israel
- Employees
- SSP N/A
- BWAY N/A
- Industry
- SSP Broadcasting
- BWAY Medical/Dental Instruments
- Sector
- SSP Industrials
- BWAY Health Care
- Exchange
- SSP Nasdaq
- BWAY Nasdaq
- Market Cap
- SSP 252.6M
- BWAY 216.8M
- IPO Year
- SSP 1988
- BWAY 2019
- Fundamental
- Price
- SSP $3.01
- BWAY $11.92
- Analyst Decision
- SSP Buy
- BWAY Strong Buy
- Analyst Count
- SSP 2
- BWAY 2
- Target Price
- SSP $5.50
- BWAY $14.25
- AVG Volume (30 Days)
- SSP 674.2K
- BWAY 47.1K
- Earning Date
- SSP 08-07-2025
- BWAY 08-13-2025
- Dividend Yield
- SSP N/A
- BWAY N/A
- EPS Growth
- SSP N/A
- BWAY N/A
- EPS
- SSP 0.48
- BWAY 0.08
- Revenue
- SSP $2,439,152,000.00
- BWAY $43,457,000.00
- Revenue This Year
- SSP N/A
- BWAY $341.83
- Revenue Next Year
- SSP $9.60
- BWAY $23.42
- P/E Ratio
- SSP $5.26
- BWAY $57.42
- Revenue Growth
- SSP 5.25
- BWAY 26.86
- 52 Week Low
- SSP $1.36
- BWAY $6.65
- 52 Week High
- SSP $4.17
- BWAY $13.66
- Technical
- Relative Strength Index (RSI)
- SSP 48.92
- BWAY 57.08
- Support Level
- SSP $2.45
- BWAY $11.63
- Resistance Level
- SSP $3.20
- BWAY $12.10
- Average True Range (ATR)
- SSP 0.25
- BWAY 0.37
- MACD
- SSP -0.06
- BWAY 0.02
- Stochastic Oscillator
- SSP 58.42
- BWAY 84.32
About SSP E.W. Scripps Company (The)
The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.